Annika Kim Constantino

The Biden administration on Wednesday said it will impose inflation penalties on 64 prescription drugs for the third quarter of this year, lowering costs for certain older Americans enrolled in Medicare.

The pharmacy chain's stock has seen steady declines for nearly a decade.

Walgreens is planning potentially sweeping store closures as it faces what its CEO called a “challenging” environment for pharmacies and U.S. consumers.

CNBC spoke with 11 current and former Pfizer employees, who asked to remain anonymous, about Pfizer's dizzying climb, rapid decline and turnaround strategy.

It's a long-awaited win for Eli Lilly after donanemab faced several delays in its path to the market, including an initial rejection from the FDA last year.

Novo Nordisk, Eli Lilly and Pfizer are developing weight loss pills. Meanwhile, digital health funding shows 'measured momentum' this year, a report said.

New study suggests that Novo Nordisk's Ozempic may lower dementia risk and nicotine use. Meanwhile, UnitedHealth Group's cyberattack woes aren't over yet.

The bill's introduction comes amid a hearing featuring testimony by UnitedHealth Group's Optum Rx, CVS Health's Caremark and Cigna's Express Scripts.

Shares of Viking Therapeutics jumped 16% in premarket trading Thursday after the biotech company a day earlier announced plans to advance its experimental weight loss injection into a late-stage trial earlier than expected.

European drug regulators on Friday rejected the Alzheimer's treatment Leqembi from Biogen and Eisai , creating another hurdle for the companies as they scramble to boost uptake of the therapy in the U.S.